Tonix Pharmaceuticals (TNXP) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-388
-259.59
-131.18
-2.77

Details

Expected EPS
-2.77
Actual EPS
-3.86
Surprise EPS
-1.09
Surprise Percent
+39.35%

Description

Tonix Pharmaceuticals (TNXP) has reported earnings of -3.86 per share for Q3 2025.

0 Comments

Share your thoughts